Television’s The Doctors covers the importance of infant gut health and new scientific evidence about why B. infantis is critical for baby's long term health, including the reduction of Antibiotic Resistance.
Sinus infections. Strep throat. Ear infections. The list of bacterial afflictions goes on and on, and you fight them the best way you know how—with antibiotics. But what happens when antibiotic-resistant bacteria disarm your trusted defense and leave baby vulnerable? The consequences can be long term with antibiotic resistance on the rise as a major global health threat.
Antibiotic resistance results from many decades of antibiotic overuse, and the subsequent rise of pathogens that harbor antibiotic-resistant genes, leading to levels of antibiotic-resistant genes in the infant gut microbiome now on the rise. In the U.S. alone, more than 2M people develop antibiotic-resistant infections every year, and 200k infants die globally each year as a result of antibiotic-resistant infections. Of the infants harboring these antibiotic-resistant ‘nightmare bacteria’ in their gut, 40% of their newborn infections are resisting standard treatment. These babies can become vectors of antibiotic-resistant genes for their communities, helping spread these bacteria to their families and playmates. Clearly, we are looking at a global health epidemic, and it’s time to start taking preventive measures now.
So what can be done to address the antibiotic resistance crisis? Given that baby’s immune system is rapidly developing during its first six months, it is critical that parents and pediatricians take fast, effective steps to reduce antibiotic-resistant genes in baby’s microbiome. And the first step is Evivo.
Our Study showed that even healthy babies can be full of antibiotic resistance genes, acquired as early as their time in the hospital during delivery. Your best defense against them is Evivo, a strong, sure, good bacteria that’s backed by clinical research. While the study found that the human gut microbiome hosts many antibiotic-resistant genes and bacteria like E. Coli, Clostridia, Staph, and Strep, it also confirmed that these potentially pathogenic bacteria lose their dangerous stronghold with B. infantis, along with the antibiotic-resistant genes that they possess.
The research showed that B. infantis successfully reduces levels of antibiotic resistance genes in the infant gut microbiome by 90%. And that’s just the beginning. B. infantis achieves this great and wonderful feat without any nasty side effects and, perhaps more importantly, without adding to antibiotic resistance. Because Evivo is B. infantis, it is a safe, easy way for you to reduce antibiotic resistance genes in your baby’s gut microbiome.
Additionally, B. infantis found in Evivo is the only probiotic that completely digests human milk oligosaccharides (HMOs) in breastmilk, lowering the pH in baby’s gut making it difficult for antibiotic-resistant bacteria to thrive.
9 out of 10 babies today lack the key beneficial bacteria, B. infantis. Evivo is the only clinically proven probiotic that restores B. infantis to the infant gut microbiome and reduces antibiotic-resistant genes in infants from the get-go. Here are some tips to keep baby safer and healthier.
The AMR Challenge was launched by the CDC to encourage governments, industries, and organizations to make formal commitments to further the progress against antimicrobial resistance. Evivo is proud to be awarded partner status in the AMR Challenge for our science demonstrating that Evivo successfully reduces levels of antibiotic resistance genes in the infant gut microbiome by 90%.
